Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection (Q37713673)

22 August 2017

1 reference

title

Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection (English)

1 reference

22 August 2017

Michael J Haas

1

1 reference

22 August 2017

Arshag D Mooradian

series ordinal

2

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

70

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

805-821

1 reference

Cholesterol transport between cells and high-density lipoproteins

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha gamma Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Transcriptional regulatory networks in lipid metabolism control ABCA1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK/ERK and JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Vitamin E in humans: an explanation of clinical trial failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Evidence That Apolipoprotein A-I Milano Has Reduced Capacity, Compared With Wild-Type Apolipoprotein A-I, to Recruit Membrane Cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.2165/11535410-000000000-00000

Why have antioxidants failed in clinical trials?

21 January 2018

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys

1 reference

12 December 2020

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

1 reference

12 December 2020

Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm.

1 reference

12 December 2020

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Molecular identification of nicotinic acid receptor

1 reference

12 December 2020

HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease

1 reference

12 December 2020

NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.

1 reference

12 December 2020

Differential tissue-specific expression of human apoA-I and apoA-II

1 reference

12 December 2020

A natural product ligand of the oxysterol receptor, liver X receptor.

1 reference

12 December 2020

Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate: a quite common phenomenon

1 reference

12 December 2020

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

1 reference

12 December 2020

Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently.

1 reference

12 December 2020

Identification of Functional Positive and Negative Thyroid Hormone-Responsive Elements in the Rat Apolipoprotein AI Promoter†

1 reference

12 December 2020

Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated rec

1 reference

12 December 2020

Genistein, a specific inhibitor of tyrosine-specific protein kinases

1 reference

12 December 2020

Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1.

1 reference

12 December 2020

Structure and function of HDL mimetics

1 reference

12 December 2020

Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein

1 reference

12 December 2020

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

12 December 2020

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

1 reference

12 December 2020

New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport

1 reference

12 December 2020

Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice.

1 reference

12 December 2020

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

12 December 2020

Thiazolidinediones are partial agonists for the glucocorticoid receptor

1 reference

12 December 2020

Reverse cholesterol transport: physiology and pharmacology

1 reference

12 December 2020

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

1 reference

12 December 2020

Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist

1 reference

12 December 2020

Identification of the thyroid hormone-responsive messenger RNA spot 11 as apolipoprotein-A1 messenger RNA and effects of the hormone on the promoter

1 reference

12 December 2020

Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.

1 reference

12 December 2020

Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides

1 reference

12 December 2020

ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study

1 reference

12 December 2020

Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial

1 reference

12 December 2020

Vitamin intake and risk of coronary disease: observation versus intervention

1 reference

12 December 2020

Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project

1 reference

12 December 2020

Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide

1 reference

12 December 2020

Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes

1 reference

12 December 2020

The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice

1 reference

12 December 2020

Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)

1 reference

12 December 2020

Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production

1 reference

12 December 2020

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins

1 reference

12 December 2020

Plasma lipid transfer proteins

1 reference

12 December 2020

Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes

1 reference

12 December 2020

Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells

1 reference

12 December 2020

Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats.

1 reference

12 December 2020

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

12 December 2020

Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids

1 reference

12 December 2020

Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Nicotinic acid: pharmacological effects and mechanisms of action

1 reference

12 December 2020

Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

1 reference

12 December 2020

Expression of the pregnane X receptor in mice antagonizes the cholic acid-mediated changes in plasma lipoprotein profile.

1 reference

12 December 2020

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

1 reference

12 December 2020

Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease?

1 reference

12 December 2020

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

1 reference

12 December 2020

Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha

1 reference

12 December 2020

Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice

1 reference

12 December 2020

Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism

1 reference

12 December 2020

Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.

1 reference

12 December 2020

Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I.

1 reference

12 December 2020

Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial

1 reference

12 December 2020

Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer.

1 reference

12 December 2020

Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta

1 reference

12 December 2020

Oestradiol decreases rat apolipoprotein AI transcription via promoter site B

1 reference

12 December 2020

Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.

1 reference

12 December 2020

Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease

1 reference

12 December 2020

Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent

1 reference

12 December 2020

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

1 reference

12 December 2020

Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1.

1 reference

12 December 2020

Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux

1 reference

12 December 2020

Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials

1 reference

12 December 2020

Nicotinic acid and the prevention of coronary artery disease

1 reference

12 December 2020

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

12 December 2020

Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines

1 reference

12 December 2020

Supplementation with Isoflavonoid Phytoestrogens Does Not Alter Serum Lipid Concentrations: A Randomized Controlled Trial in Humans ,

1 reference

12 December 2020

Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine

1 reference

12 December 2020

Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.

1 reference

12 December 2020

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

12 December 2020

The novel vitamin D analog ZK191784 as an intestine-specific vitamin D antagonist

1 reference

12 December 2020

Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models

1 reference

12 December 2020

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

12 December 2020

The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E

1 reference

12 December 2020

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1

1 reference

12 December 2020

Effects of glucose and insulin on rat apolipoprotein A-I gene expression.

1 reference

12 December 2020

Role of LCAT in HDL remodeling: investigation of LCAT deficiency states

1 reference

12 December 2020

Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line Hep G2.

1 reference

12 December 2020

Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer

1 reference

12 December 2020

Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice.

1 reference

12 December 2020

Physiological role and clinical relevance of high-density lipoprotein subclasses

1 reference

12 December 2020

Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing

1 reference

12 December 2020

Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors alpha/delta dual agonists

1 reference

12 December 2020

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

12 December 2020

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

12 December 2020

Minireview: latest perspectives on antiinflammatory actions of glucocorticoids

1 reference

12 December 2020

Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells

1 reference

12 December 2020

(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

1 reference

12 December 2020

TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processes

1 reference

12 December 2020

A natural product that lowers cholesterol as an antagonist ligand for FXR.

1 reference

12 December 2020

Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1

1 reference

12 December 2020

Effects of dehydroepiandrosterone on rat apolipoprotein AI gene expression in the human hepatoma cell line, HepG2.

1 reference

12 December 2020

Estrogen receptors and human disease

1 reference

12 December 2020

Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3

1 reference

12 December 2020

Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer

1 reference

12 December 2020

Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux

1 reference

12 December 2020

Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome

1 reference

12 December 2020

The two faces of the 'good' cholesterol.

1 reference

12 December 2020

Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.

1 reference

12 December 2020

Common variants at 30 loci contribute to polygenic dyslipidemia

1 reference

12 December 2020

Conversion of plasma free fatty acids into triglycerides of plasma lipoprotein fractions in man

1 reference

12 December 2020

Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes

1 reference

12 December 2020

Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Hepatic lipase, lipoprotein metabolism, and atherogenesis

1 reference

12 December 2020

Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone-like manner

1 reference

12 December 2020

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

1 reference

12 December 2020

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux

1 reference

12 December 2020

Activation of PPARdelta alters lipid metabolism in db/db mice.

1 reference

12 December 2020

Increased plasma HDL-cholesterol and apo A-I in breast cancer patients undergoing adjuvant tamoxifen therapy

1 reference

12 December 2020

Anti-inflammatory functions of glucocorticoid-induced genes

1 reference

12 December 2020

Dynamics of reverse cholesterol transport: protection against atherosclerosis

1 reference

12 December 2020

IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells

1 reference

12 December 2020

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial

1 reference

12 December 2020

Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice

1 reference

12 December 2020

Toll-like receptor modulation in cardiovascular disease: a target for intervention?

1 reference

12 December 2020

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

1 reference

12 December 2020

Insulin induction of apolipoprotein AI, role of Sp1.

1 reference

12 December 2020

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

1 reference

12 December 2020

Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial

1 reference

12 December 2020

Glucocorticoid increases rat apolipoprotein A-I promoter activity

1 reference

12 December 2020

Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4.

1 reference

12 December 2020

Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid

1 reference

12 December 2020

Insight into the physiological actions of thyroid hormone receptors from genetically modified mice

1 reference

12 December 2020

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

1 reference

12 December 2020

Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits

1 reference

12 December 2020

10.2165/11535410-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1011575593

0 references

1 reference